BioPharma Drug Discovery

Ginkgo Datapoints, Tangible Scientific and Inductive Bio Launch ADME One to Accelerate Early Drug Discovery

Ginkgo Datapoints, Tangible Scientific, and Inductive Bio Launch ADME-One™:  a High-Throughput ADME Platform That Brings Pharmacokinetic Projec...

 June 02, 2026 | News

Scientific Infrastructure or Expensive Theatre? AI Discovery’s Reckoning in Asia

In October 2025, Eli Lilly announced it would build the most powerful supercomputer ever owned by a drug company. By February 2026, “LillyPod” ...

 June 02, 2026 | Analysis

XtalPi Earns Second Milestone Payment As AI Drug Discovery Alliance With DoveTree Gains Momentum

XtalPi (2228.HK), an AI- and robotics- powered drug discovery platform, announced that its strategic collaboration with innovative biopharmaceutical c...

 June 02, 2026 | News

Lilly Secures Global Rights To Hanmi's Sonefpeglutide In Potential $1.26 Billion Deal

Lilly licenses Hanmi's sonefpeglutide (LAPSGLP-2 analog) for multiple indications Hanmi Pharm. Co., Ltd. ("Hanmi") announced that they have entered i...

 June 02, 2026 | News

China Developed Anaesthetic Cipepofol Secures US FDA Approval, Marking Global Breakthrough

Cipepofol (CYPSEDO) Injection (hereinafter "Cipepofol"), a Class 1 innovative intravenous anesthetic independently developed by Haisco Pharmaceutical ...

 June 02, 2026 | News

Syncell Launches Global Discovery Services To Accelerate Biomarker And Drug Target Identification

Global program expands access to unbiased nanoscopic proteomic technology to accelerate biomarker identification and drug target discovery -Syncel...

 June 01, 2026 | News

Leica Biosystems, Indica Labs, And Lunit Advance AI Powered Digital Pathology For PD L1 Biomarker Analysis

Building on the market-defining computational pathology partnership between Leica Biosystems and Indica Labs, this new collaboration integrates Lunit's adv...

 May 29, 2026 | News

CGBIO Expands Global NOVOSIS Partnership With DePuy Synthes Into North America And Australia

DePuy Synthes secures exclusive commercialization rights in North America and Australia; the two companies to jointly advance global clinical development...

 May 28, 2026 | News

Insilico Medicine And HLFM Launch AI Collaboration To Advance Human Longevity Science

Insilico Medicine ("Insilico", 3696.HK), a clinical-stage generative artificial intelligence (AI)-driven biotechnology company, and Human Life Foundation M...

 May 28, 2026 | News

AGC Biologics Selected By Teikoku Seiyaku Co., Ltd. To Advance Microbial Manufacturing For KTP 001 Disc Herniation Therapy

AGC Biologics, your friendly CDMO expert, was selected by Teikoku Seiyaku Co., Ltd., a leader in transdermal drug delivery, to provide microbial contract d...

 May 27, 2026 | News

Caliway Advances Global Phase 3 Programme For CBL 514 Following U.S. FDA IND Clearance

Asia-Pacific Phase 2 Study CBL-0206 Also Approved by Australia HREC and Taiwan TFDA, Accelerating Global Dual-Track Strategy ...

 May 26, 2026 | News

Ingenia Therapeutics Secures KRX Approval For IPO Amid Advancing TIE2 Targeted Pipeline

Ingenia Therapeutics, a clinical-stage biotechnology company pioneering next-generation vascular-targeted therapies, announced that the company has receive...

 May 26, 2026 | News

Beckman Coulter Life Sciences Commercialises Echo 650 Plus Series For Next Generation Acoustic Liquid Handling

Beckman Coulter Life Sciences, a Danaher company and global leader in laboratory automation and innovation, has announced the commercial release of the Ech...

 May 26, 2026 | News

Nuance Pharma Secures NMPA Clearance For Pivotal Actair® Allergy Trial In China

NMPA Approval Marks Key Milestone in Advancing House Dust Mite Allergy Immunotherapy to Chinese Patients Nuance Pharma announced that the National Medical...

 May 25, 2026 | News


News

Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close